Research Analysts Set Expectations for Curaleaf Q3 Earnings

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) – Research analysts at Atb Cap Markets issued their Q3 2025 EPS estimates for Curaleaf in a note issued to investors on Tuesday, March 4th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings of ($0.05) per share for the quarter. The consensus estimate for Curaleaf’s current full-year earnings is ($0.25) per share. Atb Cap Markets also issued estimates for Curaleaf’s Q4 2025 earnings at ($0.05) EPS.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09. The business had revenue of $331.05 million during the quarter, compared to analyst estimates of $331.87 million. Curaleaf had a negative net margin of 14.82% and a negative return on equity of 13.67%.

CURLF has been the subject of a number of other reports. Cormark downgraded shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th. Roth Capital upgraded shares of Curaleaf to a “strong-buy” rating in a research note on Sunday, November 10th.

Curaleaf Price Performance

Curaleaf stock opened at $1.11 on Thursday. Curaleaf has a 1 year low of $0.88 and a 1 year high of $6.40. The firm has a 50 day moving average price of $1.44 and a 200 day moving average price of $2.18. The company has a market cap of $733.29 million, a price-to-earnings ratio of -3.83 and a beta of 0.57. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.51 and a current ratio of 1.11.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.